Geneos Wealth Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Geneos Wealth Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,306	Closed	-$20K	–	2725
2022 Q2	$20K	Hold	1,306	–	–	﹤0.01%	1691
2022 Q1	$19K	Hold	1,306	–	–	﹤0.01%	1840
2021 Q4	$20K	Hold	1,306	–	–	﹤0.01%	1899
2021 Q3	$11K	Buy	1,306 +6	+0.5%	+$55	﹤0.01%	2203
2021 Q2	$13K	Hold	1,300	–	–	﹤0.01%	2115
2021 Q1	$12K	Hold	1,300	–	–	﹤0.01%	2316
2020 Q4	$15K	Hold	1,300	–	–	﹤0.01%	2070
2020 Q3	$7K	Hold	1,300	–	–	﹤0.01%	2096
2020 Q2	$10K	Buy	+1,300	New	+$11.2K	﹤0.01%	1934
2017 Q1	–	Sell	-109	Closed	-$1K	–	2163
2016 Q4	$1K	Hold	109	–	–	﹤0.01%	2029
2016 Q3	$1K	Buy	+109	New	+$1.53K	﹤0.01%	1954

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Geneos Wealth Management's NPTN Position: Q3 2022 in Review

Geneos Wealth Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 1,306 shares — an estimated $20K sold.

Geneos Wealth Management first reported a position in NPTN in Q3 2016 and held it in 11 quarters. The position peaked at $20K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Geneos Wealth Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 1,306 NEOPHOTONICS CORP shares in Q3 2022, an estimated $20K.
Geneos Wealth Management first reported a position in NEOPHOTONICS CORP in Q3 2016 and held it in 11 quarters.
Geneos Wealth Management's NEOPHOTONICS CORP position peaked at $20K in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.